<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>pioglitazone</title><link>http://www.unboundmedicine.com/medline/ebm/research/pioglitazone</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Peroxisome proliferator-activated receptor ligands reduce aortic dilatation in a mouse model of aortic aneurysm.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19926086/full_citation/Peroxisome_proliferator_activated_receptor_ligands_reduce_aortic_dilatation_in_a_mouse_model_of_aortic_aneurysm_</link><description>Golledge J, Cullen B, Rush C, et al. <br/><span class="title">Peroxisome proliferator-activated receptor ligands reduce aortic dilatation in a mouse model of aortic aneurysm. [JOURNAL ARTICLE]</span><br/><span class="source" title="Atherosclerosis">Atherosclerosis 2009 Oct 29.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19926086/abstract/Peroxisome_proliferator_activated_receptor_ligands_reduce_aortic_dilatation_in_a_mouse_model_of_aortic_aneurysm_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19926086/full_citation/Peroxisome_proliferator_activated_receptor_ligands_reduce_aortic_dilatation_in_a_mouse_model_of_aortic_aneurysm_">Full Citation</a></description></item><item><title>Activation of STAT3 and inhibitory effects of pioglitazone on STAT3 activity in a mouse model of SOD1-mutated amyotrophic lateral sclerosis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19925559/full_citation/Activation_of_STAT3_and_inhibitory_effects_of_pioglitazone_on_STAT3_activity_in_a_mouse_model_of_SOD1_mutated_amyotrophic_lateral_sclerosis_</link><description>Shibata N, Yamamoto T, Hiroi A, et al. <br/><span class="title">Activation of STAT3 and inhibitory effects of pioglitazone on STAT3 activity in a mouse model of SOD1-mutated amyotrophic lateral sclerosis. [JOURNAL ARTICLE]</span><br/><span class="source" title="Neuropathology : official journal of the Japanese Society of Neuropathology">Neuropathology 2009 Nov 18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19925559/abstract/Activation_of_STAT3_and_inhibitory_effects_of_pioglitazone_on_STAT3_activity_in_a_mouse_model_of_SOD1_mutated_amyotrophic_lateral_sclerosis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19925559/full_citation/Activation_of_STAT3_and_inhibitory_effects_of_pioglitazone_on_STAT3_activity_in_a_mouse_model_of_SOD1_mutated_amyotrophic_lateral_sclerosis_">Full Citation</a></description></item><item><title>Comparative Study of Low-dose Pioglitazone or Metformin Treatment in Japanese Diabetic Patients with Metabolic Syndrome.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19924605/full_citation/Comparative_Study_of_Low_dose_Pioglitazone_or_Metformin_Treatment_in_Japanese_Diabetic_Patients_with_Metabolic_Syndrome_</link><description>Kato T, Sawai Y, Kanayama H, et al. <br/><span class="title">Comparative Study of Low-dose Pioglitazone or Metformin Treatment in Japanese Diabetic Patients with Metabolic Syndrome. [JOURNAL ARTICLE]</span><br/><span class="source" title="Experimental and clinical endocrinology &amp; diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association">Exp Clin Endocrinol Diabetes 2009 Nov; 117(10):593-599.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19924605/abstract/Comparative_Study_of_Low_dose_Pioglitazone_or_Metformin_Treatment_in_Japanese_Diabetic_Patients_with_Metabolic_Syndrome_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19924605/full_citation/Comparative_Study_of_Low_dose_Pioglitazone_or_Metformin_Treatment_in_Japanese_Diabetic_Patients_with_Metabolic_Syndrome_">Full Citation</a></description></item><item><title>Efficacy of PPAR-gamma agonist pioglitazone in mild Alzheimer disease.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19923038/full_citation/Efficacy_of_PPAR_gamma_agonist_pioglitazone_in_mild_Alzheimer_disease_</link><description>Sato T, Hanyu H, Hirao K, et al. <br/><span class="title">Efficacy of PPAR-gamma agonist pioglitazone in mild Alzheimer disease. [JOURNAL ARTICLE]</span><br/><span class="source" title="Neurobiology of aging">Neurobiol Aging 2009 Nov 16.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19923038/abstract/Efficacy_of_PPAR_gamma_agonist_pioglitazone_in_mild_Alzheimer_disease_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19923038/full_citation/Efficacy_of_PPAR_gamma_agonist_pioglitazone_in_mild_Alzheimer_disease_">Full Citation</a></description></item><item><title>Searching for the right outcome? A systematic review and meta-analysis of controlled trials using carotid intima-media thickness or pulse wave velocity to infer antiatherogenic properties of thiazolidinediones.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19922476/full_citation/Searching_for_the_right_outcome_A_systematic_review_and_meta_analysis_of_controlled_trials_using_carotid_intima_media_thickness_or_pulse_wave_velocity_to_infer_antiatherogenic_properties_of_thiazolidinediones_</link><description>Webb DR, Davies MJ, Gray LJ, et al. <br/><span class="title">Searching for the right outcome? A systematic review and meta-analysis of controlled trials using carotid intima-media thickness or pulse wave velocity to infer antiatherogenic properties of thiazolidinediones. [JOURNAL ARTICLE]</span><br/><span class="source" title="Diabetes, obesity &amp; metabolism">Diabetes Obes Metab 2009 Nov 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19922476/abstract/Searching_for_the_right_outcome_A_systematic_review_and_meta_analysis_of_controlled_trials_using_carotid_intima_media_thickness_or_pulse_wave_velocity_to_infer_antiatherogenic_properties_of_thiazolidinediones_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19922476/full_citation/Searching_for_the_right_outcome_A_systematic_review_and_meta_analysis_of_controlled_trials_using_carotid_intima_media_thickness_or_pulse_wave_velocity_to_infer_antiatherogenic_properties_of_thiazolidinediones_">Full Citation</a></description></item><item><title>Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19921118/full_citation/Insulin_sensitizers_in_nonalcoholic_fatty_liver_disease_and_steatohepatitis:_Current_status_</link><description>Stein LL, Dong MH, Loomba R <br/><span class="title">Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status. [JOURNAL ARTICLE]</span><br/><span class="source" title="Advances in therapy">Adv Ther 2009 Nov 16.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19921118/abstract/Insulin_sensitizers_in_nonalcoholic_fatty_liver_disease_and_steatohepatitis:_Current_status_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19921118/full_citation/Insulin_sensitizers_in_nonalcoholic_fatty_liver_disease_and_steatohepatitis:_Current_status_">Full Citation</a></description></item><item><title>Molecular mechanism by which pioglitazone preserves pancreatic {beta} cells in obese diabetic mice: Evidence for acute and chronic actions as a PPAR{gamma} agonist.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19920213/full_citation/Molecular_mechanism_by_which_pioglitazone_preserves_pancreatic_{beta}_cells_in_obese_diabetic_mice:_Evidence_for_acute_and_chronic_actions_as_a_PPAR{gamma}_agonist_</link><description>Kanda Y, Shimoda M, Hamamoto S, et al. <br/><span class="title">Molecular mechanism by which pioglitazone preserves pancreatic {beta} cells in obese diabetic mice: Evidence for acute and chronic actions as a PPAR{gamma} agonist. [JOURNAL ARTICLE]</span><br/><span class="source" title="American journal of physiology. Endocrinology and metabolism">Am J Physiol Endocrinol Metab 2009 Nov 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19920213/abstract/Molecular_mechanism_by_which_pioglitazone_preserves_pancreatic_{beta}_cells_in_obese_diabetic_mice:_Evidence_for_acute_and_chronic_actions_as_a_PPAR{gamma}_agonist_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19920213/full_citation/Molecular_mechanism_by_which_pioglitazone_preserves_pancreatic_{beta}_cells_in_obese_diabetic_mice:_Evidence_for_acute_and_chronic_actions_as_a_PPAR{gamma}_agonist_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19920213/Molecular_mechanism_by_which_pioglitazone_preserves_pancreatic_{beta}_cells_in_obese_diabetic_mice:_Evidence_for_acute_and_chronic_actions_as_a_PPAR{gamma}_agonist_">Find Related Articles</a> </description></item><item><title>Pioglitazone improves virological response to peginterferon alpha-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19919569/full_citation/Pioglitazone_improves_virological_response_to_peginterferon_alpha_2b/ribavirin_combination_therapy_in_hepatitis_C_genotype_4_patients_with_insulin_resistance_</link><description>Khattab M, Emad M, Abdelaleem A, et al. <br/><span class="title">Pioglitazone improves virological response to peginterferon alpha-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance. [JOURNAL ARTICLE]</span><br/><span class="source" title="Liver international : official journal of the International Association for the Study of the Liver">Liver Int 2009 Nov 16.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19919569/abstract/Pioglitazone_improves_virological_response_to_peginterferon_alpha_2b/ribavirin_combination_therapy_in_hepatitis_C_genotype_4_patients_with_insulin_resistance_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19919569/full_citation/Pioglitazone_improves_virological_response_to_peginterferon_alpha_2b/ribavirin_combination_therapy_in_hepatitis_C_genotype_4_patients_with_insulin_resistance_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19919569/Pioglitazone_improves_virological_response_to_peginterferon_alpha_2b/ribavirin_combination_therapy_in_hepatitis_C_genotype_4_patients_with_insulin_resistance_">Find Related Articles</a> </description></item><item><title>Pioglitazone Compared with Metformin Increases Pericardial Fat Volume in Patients with Type 2 Diabetes Mellitus.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19915017/full_citation/Pioglitazone_Compared_with_Metformin_Increases_Pericardial_Fat_Volume_in_Patients_with_Type_2_Diabetes_Mellitus_</link><description>Jonker JT, Lamb HJ, van der Meer RW, et al. <br/><span class="title">Pioglitazone Compared with Metformin Increases Pericardial Fat Volume in Patients with Type 2 Diabetes Mellitus. [JOURNAL ARTICLE]</span><br/><span class="source" title="The Journal of clinical endocrinology and metabolism">J Clin Endocrinol Metab 2009 Nov 13.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19915017/abstract/Pioglitazone_Compared_with_Metformin_Increases_Pericardial_Fat_Volume_in_Patients_with_Type_2_Diabetes_Mellitus_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19915017/full_citation/Pioglitazone_Compared_with_Metformin_Increases_Pericardial_Fat_Volume_in_Patients_with_Type_2_Diabetes_Mellitus_">Full Citation</a> | <a href="http://jcem.endojournals.org/cgi/pmidlookup%3fview=long%26amp;pmid=19915017">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19915017/Pioglitazone_Compared_with_Metformin_Increases_Pericardial_Fat_Volume_in_Patients_with_Type_2_Diabetes_Mellitus_">Find Related Articles</a> </description></item><item><title>The effects of rosiglitazone and/or high glucose on protein expression in endothelial cells.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19911850/full_citation/The_effects_of_rosiglitazone_and/or_high_glucose_on_protein_expression_in_endothelial_cells_</link><description>Millioni R, Puricelli L, Iori E, et al. <br/><span class="title">The effects of rosiglitazone and/or high glucose on protein expression in endothelial cells. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of proteome research">J Proteome Res 2009 Nov 16.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19911850/abstract/The_effects_of_rosiglitazone_and/or_high_glucose_on_protein_expression_in_endothelial_cells_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19911850/full_citation/The_effects_of_rosiglitazone_and/or_high_glucose_on_protein_expression_in_endothelial_cells_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19911850/The_effects_of_rosiglitazone_and/or_high_glucose_on_protein_expression_in_endothelial_cells_">Find Related Articles</a> </description></item></channel></rss>